Company Filing History:
Years Active: 2024
Title: Mostafa Azab: Innovator in Non-Invasive Genetic Assessment
Introduction
Mostafa Azab is a prominent inventor based in San Diego, CA, known for his contributions to the field of non-invasive genetic assessment. With a total of 2 patents, he has made significant strides in developing methods that enhance the understanding of genetic alterations.
Latest Patents
Mostafa Azab's latest patents include innovative technologies aimed at non-invasive assessment of copy number alterations and genetic alterations. The first patent focuses on methods for determining the presence or absence of a copy number alteration in a test subject. This method involves providing a set of sequence reads obtained from circulating cell-free sample nucleic acid. The technology utilizes probe oligonucleotides under hybridization conditions to capture the nucleic acid, allowing for a quantification of probe coverage to determine copy number alterations. The second patent addresses non-invasive assessment of genetic alterations, utilizing a set of sequence reads that include a single molecule barcode (SMB) sequence. This method assigns sequence reads to read groups based on a read group signature, generating a consensus for each group to determine the presence or absence of genetic alterations.
Career Highlights
Mostafa Azab has made a significant impact in the field of genetic research through his work at Sequenom, Inc. His innovative approaches have paved the way for advancements in non-invasive testing methods, which are crucial for early detection and diagnosis of genetic conditions.
Collaborations
Mostafa has collaborated with notable colleagues, including Amin R Mazloom and Yijin Wu, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Mostafa Azab's work exemplifies the intersection of technology and genetics, showcasing how innovative methods can lead to significant advancements in non-invasive assessments. His contributions continue to influence the field and improve diagnostic capabilities.